BioNTech SE (BNTX) Interest Expenses (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Interest Expenses data on file, last reported at -$4.9 million in Q4 2025.

• For the quarter ending Q4 2025, Interest Expenses rose 63.69% year-over-year to -$4.9 million; the trailing twelve-month figure through Dec 2025 stood at -$77.9 million (down 121.29% YoY), and the FY2025 full-year result was -$78.9 million, down 169.34% from the prior year.
• Interest Expenses grew to -$4.9 million in Q4 2025, from -$29.5 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $211.8 million in Q2 2021 to a low of -$162.3 million in Q4 2022.
• A 5-year average of -$9.7 million and a median of -$7.7 million in 2024 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses surged 9868.43% in 2021 and tumbled 2226.11% in 2022, its largest moves.
• Tracing BNTX's Interest Expenses over 5 years: stood at -$7.0 million in 2021, then plunged by 2226.11% to -$162.3 million in 2022, then soared by 83.3% to -$27.1 million in 2023, then jumped by 50.34% to -$13.5 million in 2024, then surged by 63.69% to -$4.9 million in 2025.
• Business Quant data shows BNTX's Interest Expenses at -$4.9 million in Q4 2025, -$29.5 million in Q3 2025, and -$7.9 million in Q2 2025.